A lung cancer diagnosis can feel like the ground has vanished beneath you. If you are also staring at a bill that runs into the hundreds of thousands, or a waiting list that stretches months into the future, the fear compounds. You deserve clear, honest information — not marketing language — so you can make the best decision for yourself or someone you love.
Lung Cancer Treatment Cost in India: The Direct Answer
Lung cancer treatment cost in India typically ranges from $3,500 to $25,000 for a complete course of care, depending on the stage of disease, the treatment modality, and the hospital you choose. That figure represents a saving of 60 to 80 percent compared with equivalent treatment in the United States, the United Kingdom, or Australia — while the clinical protocols and medical technology at accredited Indian centres remain fully comparable.
This is not about cutting corners. It is about a structural cost difference: lower operating costs, government-subsidised medical education, and India’s generic pharmaceutical manufacturing rights that keep drug prices dramatically lower without affecting quality.
What Drives the Lung Cancer Treatment Cost in India
Stage at Diagnosis
Early-stage disease (Stage I or II) is usually treated with surgery alone, or surgery followed by a short adjuvant chemotherapy course. Total costs stay at the lower end of the range and hospital stays are shorter. Advanced-stage (Stage III or IV) disease often requires a combination of chemotherapy, targeted therapy, immunotherapy, and radiation, each adding to the overall cost — but still far below what patients face in Western countries or the UAE.
Type of Lung Cancer
Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) follow different treatment pathways. NSCLC with specific gene mutations — EGFR, ALK, ROS1 — responds well to daily oral targeted drugs, which are dramatically cheaper in India because of licenced generic manufacturing. SCLC typically demands aggressive combination chemotherapy cycles.
Hospital Tier and City
Internationally accredited cancer centres in Mumbai, Delhi, Chennai, Bangalore, and Hyderabad offer the latest PET-CT scanners, robotic surgery platforms, and dedicated radiation bunkers. Costs at these centres sit slightly higher than at tier-two cities, but remain a fraction of comparable Western prices. Our cancer oncology treatment page has more detail on how hospitals are ranked and selected.
Surgery for Lung Cancer in India: Costs and Approach
Surgical options range from minimally invasive video-assisted thoracoscopic surgery (VATS) lobectomy to open thoracotomy for complex or centrally located tumours. VATS is the preferred approach at leading Indian centres: smaller incisions, faster recovery, and reduced post-operative pain compared with open surgery.
A VATS lobectomy in India typically costs $5,000 to $9,000 all-in, covering surgeon fees, anaesthesia, operating theatre time, a 5-7 day hospital stay, and initial follow-up appointments. The same procedure in the United States routinely exceeds $50,000 and can approach $80,000 when complications arise. In Australia, out-of-pocket costs frequently exceed AUD 25,000 even with private health insurance.
Pneumonectomy — removal of an entire lung — is more complex and costs approximately $8,000 to $14,000 in India, depending on approach and hospital tier.
Chemotherapy Costs for Lung Cancer in India
A standard first-line chemotherapy regimen for NSCLC — such as carboplatin plus paclitaxel over 4 to 6 cycles — typically costs $3,500 to $7,500 for the full course at an accredited Indian centre. This includes drug costs, IV administration, anti-nausea medication, and routine blood monitoring between cycles.
For SCLC, regimens such as etoposide plus cisplatin run in a similar range. Port insertion for long-term IV access is an additional $400 to $800.
Targeted Therapy and Immunotherapy: What India Charges
Targeted therapy drugs for EGFR-mutant NSCLC — such as erlotinib, gefitinib, or osimertinib — are available as Indian generic formulations at dramatically lower monthly costs than anywhere in the West. A drug that costs over $5,000 per month in the US can be obtained for $150 to $400 per month in India, with the identical active molecule produced under a licenced generic.
Immunotherapy (checkpoint inhibitors such as pembrolizumab or nivolumab) involves biologic drugs that do not yet have generics. Monthly infusion costs run $1,800 to $3,500 per cycle in India — still 50 to 70 percent less than in the United States, where a single cycle can exceed $10,000.
Radiation Therapy Costs in India: IMRT, SBRT and Proton
India’s leading cancer hospitals offer the full spectrum of radiation modalities:
- IMRT (Intensity-Modulated Radiation Therapy): A full course of 25-30 fractions typically costs $3,000 to $5,500.
- SBRT/SABR (Stereotactic Ablative Radiotherapy): Used for early-stage or oligometastatic disease. A 3-5 fraction course costs approximately $3,500 to $6,000.
- Proton Therapy: Available at a small number of specialist Indian centres. Costs range from $15,000 to $25,000 — still well below the $80,000 or more seen in the United States.
Lung Cancer Treatment Cost in India vs the World
All figures are indicative 2026 ranges. Actual costs depend on specific hospital, stage, and treatment plan.
| Treatment | India | United States | United Kingdom | Australia | UAE |
|---|---|---|---|---|---|
| VATS Lobectomy (surgery) | $5,000 – $9,000 | $50,000 – $80,000 | £20,000 – £40,000 | AUD 25,000 – 60,000 | $18,000 – $30,000 |
| Chemotherapy (full course) | $3,500 – $7,500 | $30,000 – $60,000 | £15,000 – £30,000 | AUD 15,000 – 40,000 | $12,000 – $25,000 |
| Targeted Therapy (per month) | $150 – $400 | $5,000 – $10,000 | £3,000 – £7,000 | AUD 4,000 – 8,000 | $2,000 – $5,000 |
| Immunotherapy (per cycle) | $1,800 – $3,500 | $10,000 – $20,000 | £5,000 – £12,000 | AUD 8,000 – 15,000 | $4,000 – $8,000 |
| SBRT Radiation (full course) | $3,500 – $6,000 | $30,000 – $60,000 | £15,000 – £25,000 | AUD 15,000 – 30,000 | $10,000 – $20,000 |
| Proton Therapy | $15,000 – $25,000 | $80,000 – $120,000 | £50,000 – £80,000 | AUD 80,000 – 120,000 | $40,000 – $70,000 |
Why India for Lung Cancer Treatment? The Quality Case
India is not simply a lower-cost option. It is a clinically credible one.
“What surprised me most was not the price — it was the speed. I had a PET-CT scan, biopsy result, tumour board review and a confirmed surgical date within eight days of landing. At home I had already been waiting six weeks just to see a specialist.” — Representative patient experience, composite account
The quality bar in India is set by two internationally recognised standards: JCI (Joint Commission International), the global benchmark for hospital safety and clinical quality, and NABH (National Accreditation Board for Hospitals), India’s own rigorous domestic standard. India holds more JCI-accredited hospitals than any country outside the United States.
What to Look for in an Indian Lung Cancer Centre
When evaluating our hospitals, confirm each centre offers:
- A dedicated thoracic oncology unit with formal tumour board (multidisciplinary team) review
- On-site PET-CT and MRI imaging
- In-house molecular testing for EGFR, ALK, ROS1 and PD-L1 biomarker profiling
- VATS or robotic-assisted surgical capability
- Radiation oncology with IMRT and SBRT
- JCI or NABH accreditation
- An international patient services desk with multilingual coordinators
Is It Safe to Travel to India for Lung Cancer Treatment?
With the right hospital and the right preparation, yes. Most patients at Stage I through Stage III are medically fit to fly long-haul; your home oncologist and the India team will coordinate a fitness-to-fly assessment together before you book flights. The dedicated international patient departments at accredited centres are experienced with managing the transition of care and will have your full medical records reviewed before you arrive.
See how it works for a step-by-step walkthrough of the entire journey from first contact to discharge and follow-up.
Your Pre-Travel Checklist
Before travelling for lung cancer treatment in India, prepare the following:
- All imaging files in digital format: CT chest, PET-CT, MRI brain if taken (reports alone are not enough — bring the DICOM images)
- Pathology slides or tissue block for potential re-testing or molecular profiling
- Full biopsy report, including histological subtype (adenocarcinoma, squamous cell, SCLC, etc.)
- Previous treatment records if applicable: chemotherapy cycles completed, radiation doses received, prior surgery notes
- Current medication list with dosages
- Passport valid for at least six months beyond your expected return date
- India e-Medical Visa (your coordinator will provide the hospital invitation letter required for the application)
A breakdown of expected costs and what is included at each stage is available on our treatments and costs page.
How IndoMedTour Helps
When you book a free counselling call with IndoMedTour, an oncology care advisor reviews your reports, matches you with two or three accredited hospitals suited to your specific diagnosis and stage, and sends you written cost estimates — typically within 48 hours of receiving your documents. We handle the medical visa invitation letter, airport transfer, accommodation close to the hospital, and all appointment scheduling. A dedicated coordinator stays beside you from arrival day through surgery, every chemotherapy or immunotherapy cycle, and discharge — and remains your point of contact for follow-up questions once you are home. You bring the worry. We bring the plan.